Answer
Vanflyta should generally not be used during pregnancy because animal findings suggest quizartinib may cause embryo-foetal toxicity and human pregnancy data are unavailable, unless the woman’s clinical condition requires treatment.
Sources for this answer
- Vanflyta 17.7 mg film-coated tabletDaiichi Sankyo UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked